Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Should weight loss drugs like Mounjaro be widely available on the NHS? - As the NHS rolls out weight loss drugs like Mounjaro ...

Mounjaro weight loss jabs now available from GPs as NHS begins mass rollout - Around 29% of the adult population in the UK is ...

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

Suzhou-based Innovent Biologics secured approval last week for its treatment mazdutide. Read more at straitstimes.com. Read ...

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

Thousands of patients in England will be able to access weight loss jabs via their GP from Monday as they are allowed to ...